Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

GeneDx Holdings Corp.

WGS•NASDAQ
Healthcare
Medical - Healthcare Information Services
$84.64
$-6.04(-6.66%)
U.S. Market is Open • 12:27

GeneDx Holdings Corp. (WGS) Stock Overview

Explore GeneDx Holdings Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.4B
P/E Ratio1151.84
EPS (TTM)$0.11
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$90.51
3 Months$132.94
1 Year Target$190.08

WGS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GeneDx Holdings Corp. (WGS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 30.22, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $190.08.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 1151.84 and a market capitalization of 2.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-9.51%
5-Day Change
-8.90%
1-Month Change
-17.68%
3-Month Change
-38.80%
6-Month Change
-31.78%
Year-to-Date (YTD) Change
-37.97%
1-Year Change
-19.22%
3-Year Change
422.34%
5-Year Change
-88.43%
All-Time (Max) Change
-74.63%

Contact Information

http://www.genedx.com
800 298 6470
North Tower, Stamford, CT, 06902

Company Facts

10,000 Employees
IPO DateNov 4, 2020
CountryUS
Actively Trading

Frequently Asked Questions